Back to Results
First PageMeta Content



Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM
Add to Reading List

Document Date: 2015-05-13 14:14:19

Open Document

File Size: 155,88 KB

Share Result on Facebook

Company

Covidien / Bracco Diagnostics / GE Healthcare / Bayer HealthCare Pharmaceuticals / /

Country

United States / /

Event

FDA Phase / /

Facility

University of Pittsburgh Medical Center / American College of Radiology Manual / /

IndustryTerm

imaging / /

MedicalCondition

stronger dissociation / acute kidney injury / lower dissociation / significant dissociation / systemic fibrosis / severe renal disease / chronic kidney disease / nephrogenic systemic fibrosis / dissociation / /

Organization

University of Pittsburgh / European Committee for Medicinal Products for Human Use / National Science Foundation / The American College / FDA / European Society for Urological Radiology / Committee for Medicinal Products / Pittsburgh Medical Center / European Medicine Agency / /

Person

Emanuel Kanal / /

Position

Director of Magnetic Resonance Services / Professor of Radiology / /

Product

Omniscan / Optimark / Magnevist / Prohance / Multihance / Gadevist® / including Omniscan / /

Technology

MRI / Medical Imaging / /

URL

www.appliedradiology.com / /